The reproducibility of serum anti-Müllerian hormone in subfertile women: within and between patient variability

Oybek Rustamov; Philip W Pemberton; Stephen A Roberts; Alexander Smith; Allen P Yates; Sree D Patchava; Luciano G Nardo

doi:10.1016/j.fertnstert.2010.10.001

The reproducibility of serum anti-Müllerian hormone in subfertile women: within and between patient variability

Fertil Steril. 2011 Mar 1;95(3):1185-7. doi: 10.1016/j.fertnstert.2010.10.001. Epub 2010 Oct 30.

Authors

Oybek Rustamov¹, Philip W Pemberton, Stephen A Roberts, Alexander Smith, Allen P Yates, Sree D Patchava, Luciano G Nardo

Affiliation

¹ Department of Reproductive Medicine, St. Mary's Hospital, Central Manchester Foundation Trust, University of Manchester, Manchester, Lancashire, United Kingdom. [email protected]

PMID: 21036350
DOI: 10.1016/j.fertnstert.2010.10.001

Abstract

Serum anti-Müllerian hormone concentrations vary significantly over time and this should be taken into account when tailoring treatment protocols for patients undergoing controlled ovarian hyperstimulation (COH). Compared with FSH, serum anti-Müllerian hormone may have greater discriminatory power because of its modest intrapatient variation and the larger interpatient variation.

Publication types

Research Support, Non-U.S. Gov't

MeSH terms

Anti-Mullerian Hormone / blood*
Biomarkers / blood*
Female
Follicle Stimulating Hormone / blood
Humans
Infertility, Female / blood*
Infertility, Female / diagnosis*
Infertility, Female / therapy
Ovulation Induction*
Predictive Value of Tests
Reproducibility of Results

Substances

Biomarkers
Anti-Mullerian Hormone
Follicle Stimulating Hormone